Iraq's potential leader pushed bank envelope, but was he fraudulent?
Article Abstract:
Eleven years ago, a Jordanian court returned a verdict that Ahmad Chalabi embezzled funds from a bank. Mr. Chalabi is being backed by the U.S. Pentagon as a possible leader in Iraq. He maintains the case was politically motivated. Recently however, the Jordanian court records related to the case were released, documenting some of his questionable managerial activities.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
New safety setback grounds Southwest planes
Article Abstract:
Southwest Airlines Co. voluntarily grounds airplanes and cancels flights over possible safety inspection irregularities. Article discusses the airline's safety controls, recent safety-related government probes, and customer relations.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Chemical plants still have few terror controls
Article Abstract:
The Department of Homeland Security has lowered the number of chemical plants considered the most dangerous in a terrorist attack. Three years after 9-11, chemical plants are still not subject to federal security measures.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Birds: NZ's squid fleet ordered back. Russia stops 'pirate fleet'
- Abstracts: Cheney turns up rhetorical heat on Putin. Bush aims to cut energy imports, ease war anxiety. U.S. military costs face new questions: GAO and committee probe Iraq, Afghanistan missions; are all funds being used?
- Abstracts: Capital idea. From Bugs to business. Cloning Conundrum
- Abstracts: Sanofi's bird-flu vaccine is granted FDA approval: first human treatment is seen as stopgap aid as research continues